期刊文献+

雷公藤多苷和泼尼松片联合治疗特发性膜性肾病的有效性分析 被引量:4

Analysis of the Efficacy of Tripterygium Glycosides and Prednisone Tablets in the Treatment of Idiopathic Membranous Nephropathy
下载PDF
导出
摘要 目的研究雷公藤多苷和小剂量激素联合治疗特发性膜性肾病的有效性及可行性。方法选取2018年10月~2019年10月在我院治疗的108例特发性膜性肾病患者为研究对象,采用随机数字表法分为对照组和观察组,各54例。对照组采用雷公藤多苷治疗,观察组在对照组基础上应用小剂量激素治疗,比较两组临床治疗总有效率、治疗前后24h尿蛋白、血清白蛋白、血尿素氮、胆固醇水平以及临床不良反应发生情况。结果观察组临床治疗总有效率为92.59%,高于对照组的81.48%,差异有统计学意义(P<0.05);治疗后两组24h尿蛋白、血尿素氮、胆固醇水平均低于治疗前,血清白蛋白水平均高于治疗前,且观察组优于对照组,差异有统计学意义(P<0.05);观察组临床不良反应发生率低于对照组,差异有统计学意义(P<0.05)。结论雷公藤多苷和小剂量激素联合治疗特发性膜性肾病疗效确切,有助于改善肾功能指标及血脂水平,且临床不良反应少,应用安全可行。 Objective To study the efficacy and feasibility of combining tripterygium glycosides and low-dose hormone in the treatment of idiopathic membranous nephropathy.Methods A total of 108 patients with idiopathic membranous nephropathy treated in our hospital from October 2018 to October 2019 were selected as the research object.They were divided into a control group and an observation group with a random number table method,54 cases each.The control group was treated with tripterygium glycosides,and the observation group was treated with low-dose hormone therapy on the basis of the control group.The total clinical efficacy of the two groups was compared,and the 24h urine protein,serum albumin,blood urea nitrogen,cholesterol level and clinical dysfunction before and after treatment the reaction happened.Results The total effective rate of clinical treatment in the observation group was 92.59%,which was higher than 81.48%in the control group,the difference was statistically significant(P<0.05).After treatment,the 24h urine protein,blood urea nitrogen,and cholesterol levels were lower than before treatment,and the serum albumin level was higher than before treatment,and the observation group was better than the control group,the difference was statistically significant(P<0.05);observation the incidence of clinical adverse reactions in the group was lower than that in the control group,the difference was statistically significant(P<0.05).Conclusion The combination of tripterygium glycosides and low-dose hormone in the treatment of idiopathic membranous nephropathy has definite curative effect,which can help to improve the renal function indexes and blood lipid levels.
作者 鲍江波 BAO Jiang-bo(Department of Nephrology,Jiamusi Central Hospital,Jiamusi 154002,Heilongjiang,China)
出处 《医学信息》 2020年第14期157-158,共2页 Journal of Medical Information
关键词 雷公藤多苷 小剂量激素 特发性膜性肾病 Tripterygium glycosides Low-dose hormone Idiopathic membranous nephropathy
  • 相关文献

二级参考文献34

  • 1Quaglia M, Stratta P. Idiopathic membranous nephropathy : manage- ment strategies [ J ]. Drugs,2009,69 : 1303 - 1317.
  • 2Jing H, Wylln C, Pan F,et al. Tacrolimus and cyclosporin differ in their eapacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit inierleukin - 10 Produetion [ J]. Trans Plantatio, 2002,73 : 1808 - 1817.
  • 3Chen M, Li H, Li XY, et al. Tacrolimus combined with corticoste- roids in treatment of nephrotic idiopathic membranous nephropathy : a multicenter randomized controlled trial[ J]. Am J Med Sci, 2010, 339:233 - 238.
  • 4Mercadal L. Membranous nephropathy[ J]. Nephrol Ther, 2013,9 : 507 -517.
  • 5Chen ZH, Qin WS, Zeng CH, et al. Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b- 9 -induced podocyte injury in vitro [ J ]. Kidney Int, 2010, 77:974 -988.
  • 6张博.来氟米特治疗特发性膜性肾病的系统评价[D].长春:吉林大学, 2015. http://cdmd.cnki.com.cn/article/cdmd-10183-1015597706.htm.
  • 7孙广东,许钟镐,罗萍,苗里宁.他克莫司治疗特发性膜性肾病的临床疗效观察[J].中国老年学杂志,2008,28(5):469-471. 被引量:21
  • 8孙雪峰,陈香美.他克莫司在原发性肾病综合征治疗中的应用[J].中国实用内科杂志,2008,28(5):323-325. 被引量:37
  • 9陈伟珍,陈德君,徐光标.他克莫司对特发性膜性肾病的治疗观察[J].实用医学杂志,2009,25(10):1674-1675. 被引量:38
  • 10李红梅,施向东.他克莫司治疗激素抵抗性肾病综合征[J].实用医学杂志,2009,25(22):3871-3873. 被引量:18

共引文献79

同被引文献92

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部